Implementation of an infection control program with emphasis on cohorting to patients with carbapenemase-producing Enterobacteriaceae. The experience of 2 years in a tertiary teaching hospital in northern Portugal

• Published in: Porto biomedical journal Vol. 5; no. 3; p. e68
• Main Authors: Vigário, Ana, Gonçalves, João A, Costa, Ana R, Pinheiro, Guiomar, Reis, Ernestina, Oliveira, Júlio R
• Format: Journal Article
• Language: English
• Published: United States 04-06-2020
• Subjects: Original; active screening; surveillance and isolation program; infection control; antimicrobial stewardship; carbapenemase-producing Enterobacteriaceae
• ISSN: 2444-8672; 2444-8664; 2444-8672
• DOI: 10.1097/j.pbj.0000000000000068

The emergence of carbapenemase-producing Enterobacterales (CPE) represents a major public health threat. Our purpose was to evaluate a surveillance and cohorting program implemented in patients infected or carriers of CPE.
A prospective registry of CPE carriers or infected patients was analyzed from October 2015 until December 2017. All inpatients presenting with CPE were included in a hospital cohort with dedicated healthcare staff and contact precaution measures.
A total of 480 patients were identified, of which 15.8% (n = 76) were infected. Men comprised 56.7% of the cohort (n = 272) and 69.2% (n = 332) were elderly. About 46.3% (n = 222) had a previous hospital admission and 81.7% (n = 392) had at least 1 antibiotic course in the previous 90 days. There was a decline in infected patients in 2017. Periodic and admission screenings accounted for 63% and 74% of cases in 2016 and 2017, with increased detection rate comparing with contact/investigation screenings. In 2017, significantly fewer patients were identified outside the admission/point of prevalence screening (
 = .009). In 2017 the proportion of invasive carbapenem-resistant
amongst CPE in our center was below the national average (2016: 13.3% vs 5.2%; 2017: 6.6% vs 8.6%). A reduction of the consumption of carbapenems was also observed in 2017.
The implementation of the program has increased the number of patients identified by the preventive method and stabilized the emergence of new CPE cases. Furthermore, the program cohort compared well with the national picture, with a lower number of infected patients and a lower proportion of carbapenem-resistant
in invasive specimens. These indicators reflect the added value of the CPE surveillance and cohorting program.